The global ambulatory surgical center market size is evaluated at USD 105.53 billion in 2025 and is forecasted to hit around USD 155.43 billion by 2034, growing at a CAGR of 4.55% from 2025 to 2034. The North America market size was accounted at USD 43.13 billion in 2024 and is expanding at a CAGR of 4.57% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Ambulatory Surgical Center Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Ambulatory Surgical Center Market, By Ownership
8.1.1. Physician Only
8.1.1.1. Market Revenue and Forecast
8.1.2. Hospital Only
8.1.2.1. Market Revenue and Forecast
8.1.3. Corporation Only
8.1.3.1. Market Revenue and Forecast
8.1.4. Physician & Hospital
8.1.4.1. Market Revenue and Forecast
8.1.5. Physician & Corporation
8.1.5.1. Market Revenue and Forecast
8.1.6. Hospital & Corporation
8.1.6.1. Market Revenue and Forecast
9.1. Ambulatory Surgical Center Market, by Surgery Type
9.1.1. Dental
9.1.1.1. Market Revenue and Forecast
9.1.2. Otolaryngology
9.1.2.1. Market Revenue and Forecast
9.1.3. Endoscopy
9.1.3.1. Market Revenue and Forecast
9.1.4. Obstetrics / Gynecology
9.1.4.1. Market Revenue and Forecast
9.1.5. Opthalmology
9.1.5.1. Market Revenue and Forecast
9.1.6. Orthopedic
9.1.6.1. Market Revenue and Forecast
9.1.7. Cardiovascular
9.1.7.1. Market Revenue and Forecast
9.1.8. Neurology
9.1.8.1. Market Revenue and Forecast
9.1.9. Plastic Surgery
9.1.9.1. Market Revenue and Forecast
9.1.10. Podiatry
9.1.10.1. Market Revenue and Forecast
9.1.11. Others
9.1.11.1. Market Revenue and Forecast
10.1. Ambulatory Surgical Center Market, by Speciality Type
10.1.1. Multi-specialty
10.1.1.1. Market Revenue and Forecast
10.1.2. Single specialty
10.1.2.1. Market Revenue and Forecast
11.1. Ambulatory Surgical Center Market, by Service
11.1.1. Diagnosis
11.1.1.1. Market Revenue and Forecast
11.1.2. Treatment
11.1.2.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, By Ownership
12.1.2. Market Revenue and Forecast, by Surgery Type
12.1.3. Market Revenue and Forecast, by Speciality Type
12.1.4. Market Revenue and Forecast, by Service
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, By Ownership
12.1.5.2. Market Revenue and Forecast, by Surgery Type
12.1.5.3. Market Revenue and Forecast, by Speciality Type
12.1.5.4. Market Revenue and Forecast, by Service
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, By Ownership
12.1.6.2. Market Revenue and Forecast, by Surgery Type
12.1.6.3. Market Revenue and Forecast, by Speciality Type
12.1.6.4. Market Revenue and Forecast, by Service
12.2. Europe
12.2.1. Market Revenue and Forecast, By Ownership
12.2.2. Market Revenue and Forecast, by Surgery Type
12.2.3. Market Revenue and Forecast, by Speciality Type
12.2.4. Market Revenue and Forecast, by Service
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, By Ownership
12.2.5.2. Market Revenue and Forecast, by Surgery Type
12.2.5.3. Market Revenue and Forecast, by Speciality Type
12.2.5.4. Market Revenue and Forecast, by Service
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, By Ownership
12.2.6.2. Market Revenue and Forecast, by Surgery Type
12.2.6.3. Market Revenue and Forecast, by Speciality Type
12.2.6.4. Market Revenue and Forecast, by Service
12.2.7. France
12.2.7.1. Market Revenue and Forecast, By Ownership
12.2.7.2. Market Revenue and Forecast, by Surgery Type
12.2.7.3. Market Revenue and Forecast, by Speciality Type
12.2.7.4. Market Revenue and Forecast, by Service
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, By Ownership
12.2.8.2. Market Revenue and Forecast, by Surgery Type
12.2.8.3. Market Revenue and Forecast, by Speciality Type
12.2.8.4. Market Revenue and Forecast, by Service
12.3. APAC
12.3.1. Market Revenue and Forecast, By Ownership
12.3.2. Market Revenue and Forecast, by Surgery Type
12.3.3. Market Revenue and Forecast, by Speciality Type
12.3.4. Market Revenue and Forecast, by Service
12.3.5. India
12.3.5.1. Market Revenue and Forecast, By Ownership
12.3.5.2. Market Revenue and Forecast, by Surgery Type
12.3.5.3. Market Revenue and Forecast, by Speciality Type
12.3.5.4. Market Revenue and Forecast, by Service
12.3.6. China
12.3.6.1. Market Revenue and Forecast, By Ownership
12.3.6.2. Market Revenue and Forecast, by Surgery Type
12.3.6.3. Market Revenue and Forecast, by Speciality Type
12.3.6.4. Market Revenue and Forecast, by Service
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, By Ownership
12.3.7.2. Market Revenue and Forecast, by Surgery Type
12.3.7.3. Market Revenue and Forecast, by Speciality Type
12.3.7.4. Market Revenue and Forecast, by Service
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, By Ownership
12.3.8.2. Market Revenue and Forecast, by Surgery Type
12.3.8.3. Market Revenue and Forecast, by Speciality Type
12.3.8.4. Market Revenue and Forecast, by Service
12.4. MEA
12.4.1. Market Revenue and Forecast, By Ownership
12.4.2. Market Revenue and Forecast, by Surgery Type
12.4.3. Market Revenue and Forecast, by Speciality Type
12.4.4. Market Revenue and Forecast, by Service
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, By Ownership
12.4.5.2. Market Revenue and Forecast, by Surgery Type
12.4.5.3. Market Revenue and Forecast, by Speciality Type
12.4.5.4. Market Revenue and Forecast, by Service
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, By Ownership
12.4.6.2. Market Revenue and Forecast, by Surgery Type
12.4.6.3. Market Revenue and Forecast, by Speciality Type
12.4.6.4. Market Revenue and Forecast, by Service
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, By Ownership
12.4.7.2. Market Revenue and Forecast, by Surgery Type
12.4.7.3. Market Revenue and Forecast, by Speciality Type
12.4.7.4. Market Revenue and Forecast, by Service
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, By Ownership
12.4.8.2. Market Revenue and Forecast, by Surgery Type
12.4.8.3. Market Revenue and Forecast, by Speciality Type
12.4.8.4. Market Revenue and Forecast, by Service
12.5. Latin America
12.5.1. Market Revenue and Forecast, By Ownership
12.5.2. Market Revenue and Forecast, by Surgery Type
12.5.3. Market Revenue and Forecast, by Speciality Type
12.5.4. Market Revenue and Forecast, by Service
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, By Ownership
12.5.5.2. Market Revenue and Forecast, by Surgery Type
12.5.5.3. Market Revenue and Forecast, by Speciality Type
12.5.5.4. Market Revenue and Forecast, by Service
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, By Ownership
12.5.6.2. Market Revenue and Forecast, by Surgery Type
12.5.6.3. Market Revenue and Forecast, by Speciality Type
12.5.6.4. Market Revenue and Forecast, by Service
13.1. Cerner Corporation
13.1.1. Company Overview
13.1.2. Modality Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Allscripts Healthcare Solutions Inc.
13.2.1. Company Overview
13.2.2. Modality Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. McKesson Corporation
13.3.1. Company Overview
13.3.2. Modality Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Medical Information Technology Inc.
13.4.1. Company Overview
13.4.2. Modality Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Advanced Data Systems Corporation
13.5.1. Company Overview
13.5.2. Modality Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Surgical Information Systems
13.6.1. Company Overview
13.6.2. Modality Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. NextGen Healthcare
13.7.1. Company Overview
13.7.2. Modality Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Philips Healthcare
13.8.1. Company Overview
13.8.2. Modality Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Epic Systems Corporation
13.9.1. Company Overview
13.9.2. Modality Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. GE Healthcare
13.10.1. Company Overview
13.10.2. Modality Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample